Chemical formula: C₁₉H₂₅NOS Molecular mass: 315.48 g/mol PubChem compound: 59227
Rotigotine is a non-ergolinic dopamine agonist for the treatment of signs and symptoms of Parkinson’s disease and Restless Legs Syndrome.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N04BC09 | Rotigotine | N Nervous system → N04 Anti-parkinson drugs → N04B Dopaminergic agents → N04BC Dopamine agonists |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| NEUPRO 1mg/24h, 3mg/24h Transdermal patch | European Medicines Agency (EU) | MPI, EU: SmPC | |
| NEUPRO 4mg/24h, 6mg/24h, 8mg/24h Transdermal patch | European Medicines Agency (EU) | MPI, EU: SmPC | |
| NEUPRO 2mg/24h Transdermal patch | European Medicines Agency (EU) | MPI, EU: SmPC |
Rotigotine is an active ingredient of these brands:
United States (US)Australia (AU)Brazil (BR)Canada (CA)Croatia (HR)Cyprus (CY)Finland (FI)France (FR)Hong Kong (HK)Ireland (IE)Italy (IT)Japan (JP)Mexico (MX)Netherlands (NL)Romania (RO)Singapore (SG)Spain (ES)United Kingdom (UK)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
